Wednesday, September 26, 2012

Kyorin files KRP-108, an Anti-asthmatic Treatment in Japan

KRP-108 originated by Skyepharma is a LABA/ICS combination containing Fluticasone propionate (inhaled corticosteroid: ICS) and formoterol fumarate (long-acting beta-agonist: LABA). Kyorin has inlicensed the drug from Skyepharma for Japan.
 The drug comes in a Metered Dose Inhaler device which offers several advantages such as reproducible doses per actuation and suitability to patients with lowered respiratory effort. The same drug is approved and marketed in Europe under the brand name Flutiform

No comments:

Post a Comment